Top Healthcare Stocks by Free Cash Flow
Top healthcare companies ranked by free cash flow, latest annual filings.
What Free Cash Flow Means for Healthcare Companies
Free cash flow in healthcare tends to be lumpier than in most sectors because the business model swings between long pre-approval cash burns and multi-year harvesting periods once a drug or device reaches market. Large pharma and device makers with broad portfolios can produce steady cash across cycles, while single-asset biotechs often report negative free cash flow for extended periods as trials, regulatory work, and launch spending precede any revenue at all.
Why It Matters in Healthcare
For established healthcare firms, consistent free cash flow tends to signal durable payer relationships and diversified pipelines, and it is what funds research spending, acquisitions, and shareholder returns. In biotech, free cash flow is often a poor snapshot of value because cash burn is expected until approval; runway and trial timelines matter more than current cash generation. Patent cliffs and pricing pressure can also flip steady cash generators into declining ones over a few years.
What to Read Alongside
Pair free cash flow with [Net Income](/financials/top-net-income-stocks/healthcare/) to check accounting quality, [Share Buybacks](/financials/top-share-buyback-stocks/healthcare/) to see capital return behavior, and [Revenue](/financials/top-revenue-stocks/healthcare/) for how sales are converting into cash across the portfolio.
| # | Symbol | Company | Sector | ||
|---|---|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | Healthcare | $19.70B | $616.50B |
| 2 | ABBV | AbbVie Inc. | Healthcare | $17.82B | $454.79B |
| 3 | NVS | Novartis AG | Healthcare | $17.60B | $301.15B |
| 4 | UNH | UnitedHealth Group Incorporated | Healthcare | $16.07B | $382.76B |
| 5 | BMY | Bristol-Myers Squibb Company | Healthcare | $12.85B | $132.45B |
| 6 | MRK | Merck & Co., Inc. | Healthcare | $12.36B | $320.56B |
| 7 | AZN | AstraZeneca PLC | Healthcare | $11.77B | $265.73B |
| 8 | GILD | Gilead Sciences, Inc. | Healthcare | $9.46B | $162.99B |
| 9 | PFE | Pfizer Inc. | Healthcare | $9.07B | $141.97B |
| 10 | AMGN | Amgen Inc. | Healthcare | $8.10B | $209.21B |
| 11 | CVS | CVS Health Corporation | Healthcare | $7.81B | $134.25B |
| 12 | HCA | HCA Healthcare, Inc. | Healthcare | $7.69B | $85.69B |
| 13 | ABT | Abbott Laboratories | Healthcare | $7.39B | $182.75B |
| 14 | TMO | Thermo Fisher Scientific, Inc. | Healthcare | $6.29B | $214.34B |
| 15 | MCK | McKesson Corporation | Healthcare | $5.72B | $101.33B |
| 16 | MDT | Medtronic plc | Healthcare | $5.43B | $109.71B |
| 17 | DHR | Danaher Corporation | Healthcare | $5.26B | $137.90B |
| 18 | CNC | Centene Corporation | Healthcare | $4.32B | $30.05B |
| 19 | SYK | Stryker Corporation | Healthcare | $4.28B | $133.42B |
| 20 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | $4.08B | $76.02B |
| 21 | BSX | Boston Scientific Corporation | Healthcare | $3.66B | $68.37B |
| 22 | COR | Cencora, Inc. | Healthcare | $3.21B | $60.75B |
| 23 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | $3.19B | $122.26B |
| 24 | ELV | Elevance Health, Inc. | Healthcare | $3.17B | $81.63B |
| 25 | BDX | Becton, Dickinson and Co. | Healthcare | $2.67B | $45.59B |
| 26 | THC | Tenet Healthcare Corporation | Healthcare | $2.53B | $20.35B |
| 27 | ISRG | Intuitive Surgical, Inc. | Healthcare | $2.49B | $126.46B |
| 28 | ZTS | ZOETIS INC. | Healthcare | $2.28B | $31.87B |
| 29 | IQV | IQVIA Holdings Inc. | Healthcare | $2.05B | $39.14B |
| 30 | BIIB | Biogen Inc. | Healthcare | $2.05B | $30.72B |
| 31 | VTRS | Viatris Inc. | Healthcare | $1.94B | $20.68B |
| 32 | CAH | Cardinal Health, Inc. | Healthcare | $1.85B | $53.18B |
| 33 | RMD | ResMed Inc. | Healthcare | $1.66B | $30.25B |
| 34 | GEHC | GE HealthCare Technologies Inc. | Healthcare | $1.50B | $31.59B |
| 35 | ZBH | Zimmer Biomet Holdings, Inc. | Healthcare | $1.47B | $18.37B |
| 36 | DGX | Quest Diagnostics Incorporated | Healthcare | $1.36B | $25.86B |
| 37 | EW | Edwards Lifesciences Corporation | Healthcare | $1.33B | $50.05B |
| 38 | DVA | DaVita Inc. | Healthcare | $1.31B | $15.33B |
| 39 | JAZZ | Jazz Pharmaceuticals plc | Healthcare | $1.30B | $16.23B |
| 40 | MDLN | Medline Inc. | Healthcare | $1.30B | $33.08B |
| 41 | LH | Labcorp Holdings Inc. | Healthcare | $1.21B | $25.87B |
| 42 | A | Agilent Technologies Inc. | Healthcare | $1.15B | $39.18B |
| 43 | GMAB | Genmab A/S | Healthcare | $1.15B | $17.58B |
| 44 | TEVA | Teva Pharmaceutical Industries Limited | Healthcare | $1.15B | $41.23B |
| 45 | DXCM | DexCom, Inc. | Healthcare | $1.08B | $28.76B |
| 46 | OSCR | Oscar Health, Inc. | Healthcare | $1.06B | $9.42B |
| 47 | IDXX | IDEXX Laboratories, Inc. | Healthcare | $1.06B | $44.08B |
| 48 | UTHR | United Therapeutics Corporation | Healthcare | $1.04B | $26.19B |
| 49 | BHC | Bausch Health Companies Inc. | Healthcare | $1.00B | $2.25B |
| 50 | HOLX | Hologic, Inc. | Healthcare | $1.00B | $16.97B |
| 51 | STE | STERIS plc | Healthcare | $0.97B | $22.53B |
| 52 | ONC | BeOne Medicines AG | Healthcare | $0.94B | $33.42B |
| 53 | ILMN | Illumina, Inc. | Healthcare | $0.93B | $31.03B |
| 54 | EXEL | Exelixis, Inc. | Healthcare | $0.88B | $14.07B |
| 55 | ICLR | ICON Public Limited Company | Healthcare | $0.86B | $12.77B |
| 56 | UHS | Universal Health Services, Inc. | Healthcare | $0.85B | $9.88B |
| 57 | MTD | Mettler-Toledo International | Healthcare | $0.85B | $27.90B |
| 58 | NBIX | Neurocrine Biosciences, Inc. | Healthcare | $0.75B | $18.65B |
| 59 | BMRN | BioMarin Pharmaceutical Inc. | Healthcare | $0.72B | $11.71B |
| 60 | PTCT | PTC Therapeutics, Inc. | Healthcare | $0.70B | $6.26B |
| 61 | MEDP | Medpace Holdings, Inc. | Healthcare | $0.68B | $16.14B |
| 62 | ARGX | argenx SE | Healthcare | $0.68B | $54.59B |
| 63 | HALO | Halozyme Therapeutics, Inc. | Healthcare | $0.64B | $9.88B |
| 64 | GMED | Globus Medical, Inc. | Healthcare | $0.59B | $10.89B |
| 65 | HSIC | Henry Schein, Inc. | Healthcare | $0.57B | $9.70B |
| 66 | WAT | Waters Corporation | Healthcare | $0.54B | $37.34B |
| 67 | OGN | Organon & Co. | Healthcare | $0.54B | $3.56B |
| 68 | CRL | Charles River Laboratories International, Inc. | Healthcare | $0.52B | $11.30B |
| 69 | RVTY | Revvity, Inc. | Healthcare | $0.51B | $12.67B |
| 70 | AVTR | Avantor, Inc. | Healthcare | $0.49B | $9.37B |
| 71 | ALGN | Align Technology, Inc. | Healthcare | $0.49B | $12.42B |
| 72 | ALKS | Alkermes plc | Healthcare | $0.48B | $8.39B |
| 73 | WST | West Pharmaceutical Services, Inc. | Healthcare | $0.47B | $23.90B |
| 74 | ALNY | Alnylam Pharmaceuticals, Inc. | Healthcare | $0.47B | $27.50B |
| 75 | HQY | HealthEquity, Inc. | Healthcare | $0.46B | $8.44B |
| 76 | QGEN | Qiagen N.V. | Healthcare | $0.45B | $8.55B |
| 77 | EHC | Encompass Health Corporation | Healthcare | $0.44B | $11.00B |
| 78 | COO | The Cooper Companies, Inc. | Healthcare | $0.43B | $14.17B |
| 79 | BTSG | BrightSpring Health Services, Inc. | Healthcare | $0.39B | $14.30B |
| 80 | PODD | Insulet Corporation | Healthcare | $0.38B | $11.48B |
| 81 | HUM | Humana Inc. | Healthcare | $0.38B | $44.03B |
| 82 | BIO | Bio-Rad Laboratories, Inc. | Healthcare | $0.37B | $8.74B |
| 83 | RDY | Dr. Reddy's Laboratories Limited | Healthcare | $0.36B | $9.85B |
| 84 | EXAS | Exact Sciences Corp | Healthcare | $0.36B | $20.03B |
| 85 | HRMY | Harmony Biosciences Holdings, Inc. | Healthcare | $0.35B | $2.08B |
| 86 | BCRX | BioCryst Pharmaceuticals, Inc. | Healthcare | $0.34B | $2.35B |
| 87 | BAX | Baxter International Inc. | Healthcare | $0.33B | $13.82B |
| 88 | COLL | Collegium Pharmaceutical, Inc. | Healthcare | $0.33B | $1.17B |
| 89 | DOCS | Doximity, Inc. | Healthcare | $0.33B | $3.82B |
| 90 | CHE | Chemed Corporation | Healthcare | $0.33B | $7.10B |
| 91 | ATR | AptarGroup, Inc. | Healthcare | $0.30B | $8.54B |
| 92 | TDOC | Teladoc Health, Inc. | Healthcare | $0.29B | $1.20B |
| 93 | ELAN | Elanco Animal Health Incorporated | Healthcare | $0.28B | $13.22B |
| 94 | WAY | Waystar Holding Corp. | Healthcare | $0.28B | $4.02B |
| 95 | AMRX | Amneal Pharmaceuticals, Inc. | Healthcare | $0.27B | $5.91B |
| 96 | HAE | Haemonetics Corporation | Healthcare | $0.26B | $3.85B |
| 97 | TECH | Bio-Techne Corporation | Healthcare | $0.26B | $11.22B |
| 98 | PBH | Prestige Consumer Healthcare Inc. | Healthcare | $0.25B | $2.37B |
| 99 | NUTX | Nutex Health Inc. | Healthcare | $0.25B | $1.02B |
| 100 | TBPH | Theravance Biopharma, Inc. | Healthcare | $0.24B | $0.87B |
No companies match this search.
How this ranking is built
Companies are ranked by free cash flow as reported in their most recent annual filing with the SEC. Figures shown are in US dollars (or percent, as noted), rounded to two decimals.
- Source: annual 10-K / 20-F filings from companies trading on US exchanges (NYSE, Nasdaq, AMEX).
- Fiscal year: whichever annual period the company has most recently filed. Fiscal years don't always align with the calendar year, so the "as of FY" stamp above reflects the most common year across the table.
- Filtered out: warrants, preferred shares, and duplicate listings that share a parent company's financials.
- Update cadence: refreshed as companies file new annual reports (typically within 60–90 days of fiscal year end).
Not financial advice. This is a research tool, not a recommendation.